BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 35235157)

  • 1. The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.
    Paul U; Banerjee S
    Mol Biol Rep; 2022 Jul; 49(7):6899-6918. PubMed ID: 35235157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Alterations Affecting Competitive Endogenous RNAs (ceRNAs) and Regulatory Networks (ceRNETs) with Clinical Implications in Triple-Negative Breast Cancer (TNBC).
    Qattan A
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.
    Liu YR; Jiang YZ; Xu XE; Yu KD; Jin X; Hu X; Zuo WJ; Hao S; Wu J; Liu GY; Di GH; Li DQ; He XH; Hu WG; Shao ZM
    Breast Cancer Res; 2016 Mar; 18(1):33. PubMed ID: 26975198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of miRNA and lncRNA in triple-negative breast cancer.
    Xu J; Wu KJ; Jia QJ; Ding XF
    J Zhejiang Univ Sci B; 2020 Sept.; 21(9):673-689. PubMed ID: 32893525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of long noncoding RNA in triple-negative breast cancer.
    Das PK; Siddika A; Rashel KM; Auwal A; Soha K; Rahman MA; Pillai S; Islam F
    Cancer Med; 2023 Oct; 12(20):20365-20379. PubMed ID: 37795578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer.
    Yang Q; Fu Y; Wang J; Yang H; Zhang X
    J Zhejiang Univ Sci B; 2023 Dec; 24(12):1123-1140. PubMed ID: 38057269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ-FOXO3 inhibits triple-negative breast cancer growth and metastasis via regulating WHSC1-H3K36me2-Zeb2 axis.
    Chen D; Zeng S; Qiu H; Yang M; Lin X; Lv X; Li P; Weng S; Kou S; Luo K; Liu Z; Yi Y; Liu H
    Cell Signal; 2024 May; 117():111079. PubMed ID: 38341124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer.
    Lv M; Xu P; Wu Y; Huang L; Li W; Lv S; Wu X; Zeng X; Shen R; Jia X; Yin Y; Gu Y; Yuan H; Xie H; Fu Z
    Oncotarget; 2016 Mar; 7(11):13047-59. PubMed ID: 26910840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNAs: biology and clinical significance of breast cancer.
    Wang Z; Deng H; Jin Y; Luo M; Huang J; Wang J; Zhang K; Wang L; Zhou J
    RNA Biol; 2023 Jan; 20(1):859-874. PubMed ID: 37882644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of three miRNA signature as potential diagnostic marker for triple negative breast cancer patients.
    Kumar V; Gautam M; Chaudhary A; Chaurasia B
    Sci Rep; 2023 Dec; 13(1):21643. PubMed ID: 38062163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long non-coding RNA OLBC15 promotes triple-negative breast cancer progression via enhancing ZNF326 degradation.
    Deng C; Zhang B; Zhang Y; Xu X; Xiong D; Chen X; Wu J
    J Clin Lab Anal; 2020 Aug; 34(8):e23304. PubMed ID: 32329931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targets and therapeutic strategies for triple-negative breast cancer.
    Bhat Y; Thrishna MR; Banerjee S
    Mol Biol Rep; 2023 Dec; 50(12):10535-10577. PubMed ID: 37924450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles-associated miRNAs in triple-negative breast cancer: from tumor biology to clinical relevance.
    Berti FCB; Tofolo MV; Nunes-Souza E; Marchi R; Okano LM; Ruthes M; Rosolen D; Malheiros D; Fonseca AS; Cavalli LR
    Life Sci; 2024 Jan; 336():122332. PubMed ID: 38070862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNAs in the prognosis of triple-negative breast cancer: A review.
    Anilkumar KV; Rema LP; John MC; Vanesa John T; George A
    Life Sci; 2023 Nov; 333():122183. PubMed ID: 37858714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding the regulatory roles of non-coding RNAs in cellular metabolism and disease.
    Zong Y; Wang X; Cui B; Xiong X; Wu A; Lin C; Zhang Y
    Mol Ther; 2023 Jun; 31(6):1562-1576. PubMed ID: 37113055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiRNA-related metastasis in oral cancer: moving and shaking.
    Eslami M; Khazeni S; Khanaghah XM; Asadi MH; Ansari MA; Garjan JH; Lotfalizadeh MH; Bayat M; Taghizadieh M; Taghavi SP; Hamblin MR; Nahand JS
    Cancer Cell Int; 2023 Aug; 23(1):182. PubMed ID: 37635248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Cell RNA-Seq Reveals Heterogeneous lncRNA Expression in Xenografted Triple-Negative Breast Cancer Cells.
    Pinkney HR; Black MA; Diermeier SD
    Biology (Basel); 2021 Sep; 10(10):. PubMed ID: 34681087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA: new star, new hope in cancer.
    Zhang Z; Xie Q; He D; Ling Y; Li Y; Li J; Zhang H
    BMC Cancer; 2018 Aug; 18(1):834. PubMed ID: 30126353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma.
    Montico B; Giurato G; Pecoraro G; Salvati A; Covre A; Colizzi F; Steffan A; Weisz A; Maio M; Sigalotti L; Fratta E
    Mol Oncol; 2022 Feb; 16(3):565-593. PubMed ID: 34080276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic potential of circular RNA in triple-negative breast cancer.
    Xu A; Zhu L; Yao C; Zhou W; Guan Z
    Cancer Drug Resist; 2024; 7():13. PubMed ID: 38835343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.